Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
administrative support for research projects at CEBD. You will primarily be supporting the RAPID Eczema Trials programme; a National Institute for Health and Care Research (NIHR) funded applied research programme
-
Nottingham University Hospitals NHS Trust and the University of Nottingham funded by National Institute for Health and Care Research (NIHR). The mission of the NIHR Nottingham Biomedical Research Centre (BRC
-
of National Institute for Health Research funded Nottingham Biomedical Research Centre (https://nottinghambrc.nihr.ac.uk/). Medical Gastroenterology/Hepatology has the largest dedicated academic training
-
is funded by the NIHR (National Institute of Health and Care Research) Nottingham Biomedical Research Centre. The studentship will cover home University rates which includes a stipend of £18,622 per
-
PhD student in the MR&PI theme you would be a National Institute for Health and Care Research (NIHR) trainee with access to its broad-ranging training opportunities. You would also become a member of
-
Hoare [email protected] Location: NIHR Nottingham Biomedical Research Centre, Ropewalk House, Nottingham. Funding status: This studentship is funded by the NIHR (National Institute of Health
-
and/or clinical trials to take a senior role in the National Institute for Health and Care Research (NIHR) Research Support Service (RSS Hub) delivered by University of Leicester and Partners. This post
-
Papoutselou [[email protected]] Supervisor 3: Guangting Mai [[email protected]] Funding status: National Institute for Health Research. Tax-free stipend of £18,622 per annum
-
the NIHR (National Institute of Health and Care Research) Nottingham Biomedical Research Centre. The studentship will cover home University rates which includes a stipend of £ 19,553.10 per annum and tuition
-
-the-art facilities, and work as part of the £23m National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre (BRC). The project, funded by Accession Therapeutics, will study the